{"cluster": 37, "subcluster": 19, "abstract_summ": "The spectrum of acute neurological dysfunctions may implicate direct viral invasion, para-infectious complications, neurological manifestations of systemic diseases, or co-incident neurological dysfunction in the context of high SARS-CoV-2 prevalence.The primary study outcome is the overall prevalence of neurological complications among hospitalized COVID-19 patients, which will be calculated by pooled estimates of each neurological finding divided by the average census of COVID-19 positive patients over the study period.RESULTS: Neurological manifestations potentially related to COVID\u201019 have been reported in large studies, case series and case reports and include acute cerebrovascular diseases, impaired consciousness, cranial nerve manifestations and auto\u2010immune disorders such as Guillain\u2010Barr\u00e9 Syndrome often present in patients with more severe COVID\u201019.CONCLUSION: Physicians should be aware of the neurological manifestations in patients with COVID\u201019, especially when rapid clinical deterioration occurs.The innovative and pragmatic tiered study approach has allowed for rapid recruitment and activation of numerous sites across the world\u2014an approach essential to capture real-time critical neurological data to inform treatment strategies in this pandemic crisis.", "title_summ": "The Challenge of Managing Parkinson\u2019s Disease Patients during the COVID-19 Pandemic2019-NCoV: What Every Neurologist Should Know?Coronavirus disease (COVID-19) in neurology and neurosurgery: A scoping review of the early literatureGlobal Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and RationaleNeurological manifestations and neuro\u2010invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2", "title_abstract_phrases": "The spectrum of acute neurological dysfunctions may implicate direct viral invasion, para-infectious complications, neurological manifestations of systemic diseases, or co-incident neurological dysfunction in the context of high SARS-CoV-2 prevalence.The primary study outcome is the overall prevalence of neurological complications among hospitalized COVID-19 patients, which will be calculated by pooled estimates of each neurological finding divided by the average census of COVID-19 positive patients over the study period.The innovative and pragmatic tiered study approach has allowed for rapid recruitment and activation of numerous sites across the world\u2014an approach essential to capture real-time critical neurological data to inform treatment strategies in this pandemic crisis.RESULTS: Neurological manifestations potentially related to COVID\u201019 have been reported in large studies, case series and case reports and include acute cerebrovascular diseases, impaired consciousness, cranial nerve manifestations and auto\u2010immune disorders such as Guillain\u2010Barr\u00e9 Syndrome often present in patients with more severe COVID\u201019.CONCLUSION: Physicians should be aware of the neurological manifestations in patients with COVID\u201019, especially when rapid clinical deterioration occurs."}